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Using Cord Blood
The ASBMT Position Statement on Collection
and Preservation of Cord Blood for Personal Use
and the underlying ASBMT Committee Report [1,2]
were recently published in BBMT. These documents
give the likelihood of autologous use of a stored cord
blood (CB) unit as between 0.04% and 0.0005% (with-
out specifying the age of the recipient), citing several
papers as sources for these estimates [3-7]. This is
a very wide range, and review of the citations does
not reveal the origin of the lower probability. The
1997 paper by Johnson [3] arrived at the estimate of
0.04% using the incidence, in the first 21 years of
life, of diseases treatable with autologous transplanta-
tion. Although presented by Johnson as the probability
of needing an autologous transplant, it has frequently
been interpreted as the likelihood of receiving an autol-
ogous cord blood transplant.
Because valid estimates of the likelihood of trans-
plantation must underlie any estimates of the autolo-
gous (or allogeneic) use of cord blood (or adult donor
grafts), we call attention to our paper in the same issue
of BBMT, where we presented calculations designed to
estimate the likelihood of receiving an autologous or
allogeneic (assuming universal donor availability) he-
matopoietic stem cell transplant (HSCT) under a vari-
ety of scenarios [8]. Assuming stability of current
indications, that likelihood is 0.06% by age 20,
0.15% by age 40, and 0.46% by age 70 years, higher
than generally appreciated. If one restricts the consid-
eration to current indications for autologous transplan-
tation, the corresponding figures are 0.02%, 0.05%,
and 0.23%. Our 0.02% by age 20 is lower than the
0.04% estimate of Johnson for the first 21 years of
life, although Johnson states that his ‘‘is very likely
a gross overestimate’’
Our probabilities for receiving an autologous trans-
plant, as a function of age, cannot be directly translated
into the likelihood of using a stored CB unit for autol-
ogous transplantation. For example, a single CB unit
may not contain sufficient cells to transplant a large
adult. However, as the ASBMT periodically reviews
its Position Statement, we believe that the estimates
in our paper can be used as the most accurate starting
point for making predictions about the use of cord
blood in family banks and public banks (for either au-
tologous or allogeneic transplants), especially if ways24are found to overcome the limitations of low CB cell
dose for adult patients, who then might be considered
appropriate candidates for CB transplantation.
Our estimates of the probability of needing an allo-
geneic HCT are 0.04% by age 20, 0.10% by age 40,
and 0.25% by age 70 years. Unfortunately, a consider-
able number of patients needing an allograft cannot
find a suitable donor or CB unit. The probability of
actually receiving an allogeneic HCT will be greatly
enhanced when more CB units are available for such
transplants.
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